SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-072294
Filing Date
2020-06-11
Accepted
2020-06-11 12:13:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2022412d1_sc13g.htm SC 13G 46390
  Complete submission text file 0001104659-20-072294.txt   47721
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: SC 13G | Act: 34 | File No.: 005-89881 | Film No.: 20956657
SIC: 2834 Pharmaceutical Preparations

Mailing Address 366 MADISON AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address
Jatwes Ari (Filed by) CIK: 0001814776 (see all company filings)

Type: SC 13G